Latest Updates
|
June 2010 Marketed Drug
Updates and Additions
|
Brand Name
|
Generic Name
|
Other Designation
|
Abraxane |
Nanoparticle albumin-bound (nab) paclitaxel, paclitaxel albumin bound (PAB) |
ABI-007 |
Folotyn |
Pralatrexate |
PDX |
|
Oxaliplatin |
|
Nexavar |
Sorafenib tosylate |
BAY 43-9006 |
Revlimid (formerly Revimid), Lenalidomide-Celgene Europe |
Lenalidomide |
CDC501, CDC-501, CDC-5013, CC5013, CC-5013 |
Eloxatin, Eloxatine, Elplat (Japan) |
Oxaliplatin (L-OHP) |
1670RB, RP 54780 |
Tasigna |
Nilotinib |
AMN107, AMN-107 |
Sutent |
Sunitinib malate |
SU011248, SU11248, SU-11248 |
Jevtana |
Cabazitaxel |
XRP6258, XRP 6258 (formerly RPR116258, RPR116258A, 116258) |
Mylotarg |
Gemtuzumab ozogamicin |
CMA-676, CDP771 |
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|